Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing safety monitoring of lyophilized human rabies vaccine (Vero cells)
ChiCTR2300074983Phase 4Not yet recruiting
- Sponsor
- Sichuan Center for Disease Control and Prevention
- Start
- Sep 2023
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of Purified Vero cell rabies vaccine in rabies (3 arms), sponsored by Sichuan Center for Disease Control and Prevention. Primary endpoint: Safety. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
Purified Vero cell rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on ChiCTR2300074983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074983.